Japan · Delayed Price · Currency is JPY Riken Vitamin Statistics
Total Valuation
Riken Vitamin has a market cap or net worth of JPY 93.34 billion. The enterprise value is 82.88 billion.
| Market Cap | 93.34B |
| Enterprise Value | 82.88B |
Important Dates
The last earnings date was Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Sep 29, 2026 |
Share Statistics
Riken Vitamin has 29.03 million shares outstanding. The number of shares has decreased by -3.70% in one year.
| Current Share Class | 29.03M |
| Shares Outstanding | 29.03M |
| Shares Change (YoY) | -3.70% |
| Shares Change (QoQ) | -0.36% |
| Owned by Insiders (%) | 11.42% |
| Owned by Institutions (%) | 29.69% |
| Float | 18.54M |
Valuation Ratios
The trailing PE ratio is 13.33 and the forward PE ratio is 12.64.
| PE Ratio | 13.33 |
| Forward PE | 12.64 |
| PS Ratio | 0.95 |
| PB Ratio | 1.11 |
| P/TBV Ratio | 1.12 |
| P/FCF Ratio | 84.85 |
| P/OCF Ratio | 15.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.01, with an EV/FCF ratio of 75.35.
| EV / Earnings | 11.71 |
| EV / Sales | 0.84 |
| EV / EBITDA | 7.01 |
| EV / EBIT | 12.22 |
| EV / FCF | 75.35 |
Financial Position
The company has a current ratio of 3.51, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.51 |
| Quick Ratio | 2.18 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | 6.73 |
| Interest Coverage | 62.25 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.40% |
| Return on Capital Employed (ROCE) | 6.87% |
| Weighted Average Cost of Capital (WACC) | 4.01% |
| Revenue Per Employee | 52.03M |
| Profits Per Employee | 3.75M |
| Employee Count | 1,887 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Riken Vitamin has paid 3.24 billion in taxes.
| Income Tax | 3.24B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.22% in the last 52 weeks. The beta is -0.00, so Riken Vitamin's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | +10.22% |
| 50-Day Moving Average | 3,071.68 |
| 200-Day Moving Average | 2,959.73 |
| Relative Strength Index (RSI) | 58.78 |
| Average Volume (20 Days) | 64,945 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Riken Vitamin had revenue of JPY 98.18 billion and earned 7.08 billion in profits. Earnings per share was 241.10.
| Revenue | 98.18B |
| Gross Profit | 30.14B |
| Operating Income | 6.79B |
| Pretax Income | 10.33B |
| Net Income | 7.08B |
| EBITDA | 11.83B |
| EBIT | 6.79B |
| Earnings Per Share (EPS) | 241.10 |
Balance Sheet
The company has 17.91 billion in cash and 7.40 billion in debt, with a net cash position of 10.50 billion or 361.73 per share.
| Cash & Cash Equivalents | 17.91B |
| Total Debt | 7.40B |
| Net Cash | 10.50B |
| Net Cash Per Share | 361.73 |
| Equity (Book Value) | 84.40B |
| Book Value Per Share | 2,905.42 |
| Working Capital | 46.67B |
Cash Flow
In the last 12 months, operating cash flow was 5.96 billion and capital expenditures -4.86 billion, giving a free cash flow of 1.10 billion.
| Operating Cash Flow | 5.96B |
| Capital Expenditures | -4.86B |
| Depreciation & Amortization | 5.05B |
| Net Borrowing | -2.77B |
| Free Cash Flow | 1.10B |
| FCF Per Share | 37.89 |
Margins
| Gross Margin | n/a |
| Operating Margin | 6.91% |
| Pretax Margin | 10.52% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 1.14% |
Dividends & Yields
This stock pays an annual dividend of 110.00, which amounts to a dividend yield of 3.42%.
| Dividend Per Share | 110.00 |
| Dividend Yield | 3.42% |
| Dividend Growth (YoY) | 1.38% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | 3.70% |
| Shareholder Yield | 7.12% |
| Earnings Yield | 7.58% |
| FCF Yield | 1.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 30, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Mar 30, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |